Solvay expands its successful peptide activities through the incorporation of Peptisyntha, Inc. in the US
Peptisyntha, Inc. strengthens the position of the Solvay Group in the field of peptides by bringing R&D synergies with Belgium-based Peptisyntha S.A., a leading manufacturer of peptides with a proprietary solution-phase technology. The new company will offer peptides ranging from research samples to commercial quantities required by potential customers to support the development of their pharmaceutical products.
"The Solvay Group's peptide business enjoys excellent growth and its sales have increased many-fold in recent years. With Peptisyntha, Inc., Solvay will have a US-platform to initiate and further develop R&D and commercial contacts in the important US market" said Mr. A. Hoffait, Manager of Solvay's peptide business.
Peptisyntha S.A. is a wholly owned subsidiary of Solvay S.A. and is dedicated to the production of peptides. It owes its success to an original synthesis process born from a partnership with the University of Gent, Belgium and subsequently developed by Solvay's research teams. The Peptisyntha industrial plant is located on the Solvay Research and Technology site in Brussels (Belgium). Production facilities have been audited successfully by the American Food and Drug Administration. They have expanded several times, with the latest expansion, to start soon, aiming at doubling the existing capacity to respond to the growth and diversification in demand for peptides.
Peptides consist of specific chains of natural and/or synthetic amino acids. Many peptides play important roles in the regulation of various physiological functions and, therefore, are used as active ingredients by the pharmaceutical industry in a broad range of therapeutic applications.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.